- Michael Sabado
Help 4 HD Annual Report 2019
88 views0 comments
Search
Recent Posts
See AlluniQure Announces Positive Recommendation from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease ~ No Significant Safety Concerns Observed